Furthermore, only 10 patients showed a regressive trajectory of KRAS (mutKRAS → wtKRAS) and this was related to the lower incidence of this effect if compared to the progressive trajectory (wtKRAS → mutKRAS) which represents an advantageous gain for cancer cells. Here, KRAS is linked to cancer.